Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study

This study has been completed.
Cardiokine Biopharma, LLC
Information provided by:
CardioKine Inc. Identifier:
First received: May 8, 2008
Last updated: June 20, 2011
Last verified: November 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)